July 2020 - Portal Instruments has been selected as a finalist for the 2020 New England Innovation Awards. The Massachusetts Innovation Network is pleased to announce the 25 finalists of the Annual New England Innovation Awards, the oldest and longest-running innovation program in New England.
The Massachusetts Innovation Network is pleased to announce the 25 finalists of the Annual New England Innovation Awards, the oldest and longest-running innovation program in New England. The awards recognize, support and publicize ground-breaking solutions and pioneering advancements in a variety of business sectors, that shape tomorrow’s economy. Historically, the Awards have helped catapult start-ups and young companies to success (Genzyme, Ben & Jerry’s Ice Cream, zipcar, iRobot, KRONOS, MassChallenge, Vistaprint, and Staples) for the past 35 years.
Read the full press release here.
September 28, 2021 - Cambridge, MA Portal Instruments, developer of the PRIME needle-free drug delivery platform, announced that a new clinical study demonstrating patient preference for PRIME needle-free injections was published this month in the journal Drug Delivery.
January 18, 2022 - Despite recent innovations, like the launch in Europe of the first electromechanical reusable and connected auto-injector (UCB’s CIMZIA ava Connect® in early 2021), almost all new biologic drugs are launched with specific and undifferentiated self-injection options...
November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
Please fill out the details below and we will get back to you shortly.